Radiofrequency ablation for large liver cancers using a switchin controller

Radiofrequency ablation for large liver cancers using a switchin controller - RFA for large liver cancers using a switchin controller

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002505

Enrollment

Registered

2009-09-16

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

12-months enrollment. 12-month follow-up. Number of subjects: 20.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with liver cacer diagnosed by biopsy or combination of radiographic findings and tumor markers. 2. The maximum tumor size of 3-10 cm with a tumor number of 3 or less. 3. Child-Pugh grade A liver profile. 4. Not a surgical candidate. 5. Afe of 20 years or more. 6. PS of 1 or 1. 7. Life-expectancy of 2 months or longer. 8. Informed consent from the patient.

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulability. a) platelet count of 50000/mm3 or less. b) INR larger than 1.5. 2. Vascular and biliary invasion. 3. Extrahepatic metastasis.

Design outcomes

Primary

Measure	Time frame
Complication after liver radiofrequency	—

Countries

Japan

Contacts

Public ContactAtsuhiro Nakatsuka

Mie University Hospital Interventional Radiology

nakatuka@clin.medic.mie-u.ac.jp059-231-5029

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026